(Bloomberg) -- After a string of lackluster deals, the biotech industry is looking to four debutants expected to price first-time share sales in the coming weeks to see if they can reignite the sector ...

BioAge Labs filed confidentially on May 31, 2024. Goldman Sachs, Morgan Stanley, Jefferies, and Citi are the joint bookrunners on the deal. No pricing terms were disclosed.

Sept 3 (Reuters) - BioAge Labs, an obesity therapy-focused startup that has also collaborated with Eli Lilly (LLY.N), opens new tab, filed for an initial public offering in the United States on ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

(Reuters) -BioAge Labs, an obesity therapy-focused startup that has also collaborated with Eli Lilly (NYSE:LLY), filed for an initial public offering in the United States on Tuesday as it looks to ...

(Reuters) - BioAge Labs, a biotech startup collaborating with Eli Lilly for its obesity therapy, said on Tuesday it had filed for an initial public offering in the United States. The move comes months ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, has filed for an initial public offering. The company said Tuesday in a filing with ...

Medtech startup Toku Eyes is hoping to raise between US$15 million and US$20m ($24m and $32m) in a Series B round under way as it rolls out its first product. The Auckland University spin-out uses ...

Another popular Lexington sushi restaurant is expanding: Zundo Izakaya & Ramen, which opened on Nicholasville Road near Fayette Mall in 2022 at 127 West Tiverton Way #183, is adding Toku Revolving ...